Metabolites 2013, 3(3), 552-574; doi:10.3390/metabo3030552
Review

A Review of Applications of Metabolomics in Cancer

National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA
Received: 24 April 2013; in revised form: 17 May 2013 / Accepted: 24 June 2013 / Published: 5 July 2013
(This article belongs to the Special Issue Cancer Metabolomics)
PDF Full-text Download PDF Full-Text [262 KB, uploaded 5 July 2013 14:15 CEST]
Abstract: Cancer is a devastating disease that alters the metabolism of a cell and the surrounding milieu. Metabolomics is a growing and powerful technology capable of detecting hundreds to thousands of metabolites in tissues and biofluids. The recent advances in metabolomics technologies have enabled a deeper investigation into the metabolism of cancer and a better understanding of how cancer cells use glycolysis, known as the “Warburg effect,” advantageously to produce the amino acids, nucleotides and lipids necessary for tumor proliferation and vascularization. Currently, metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions.
Keywords: cancer; metabolomics; metabonomics; personalized medicine; biomarker

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Beger, R.D. A Review of Applications of Metabolomics in Cancer. Metabolites 2013, 3, 552-574.

AMA Style

Beger RD. A Review of Applications of Metabolomics in Cancer. Metabolites. 2013; 3(3):552-574.

Chicago/Turabian Style

Beger, Richard D. 2013. "A Review of Applications of Metabolomics in Cancer." Metabolites 3, no. 3: 552-574.

Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert